<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The authors report 2 cases of hepatocellular <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> in children treated with anabolic <z:chebi fb="5" ids="50113">androgens</z:chebi> for <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>In both cases, the presentation was by a picture of <z:hpo ids='HP_0011009'>acute</z:hpo> abdomen due to <z:hpo ids='HP_0011854'>hemoperitoneum</z:hpo> caused by <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> rupture </plain></SENT>
<SENT sid="2" pm="."><plain>In the first case, there was multiple <z:hpo ids='HP_0012028'>hepatic adenomas</z:hpo> necessitating right hepatic lobectomy </plain></SENT>
<SENT sid="3" pm="."><plain>The second infant had a <z:e sem="disease" ids="C1298180" disease_type="Neoplastic Process" abbrv="">single tumour</z:e> of segment IV treated by simple excision of the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>It was a <z:hpo ids='HP_0001402'>hepatocellular-carcinoma</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>Follow-up for one year after the initial operation showed no signs of recurrence in both infants </plain></SENT>
<SENT sid="6" pm="."><plain>The review of the literature permitted us to find 48 other cases of hepatocellular <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> secondary to <z:chebi fb="3" ids="50113">androgen</z:chebi> therapy </plain></SENT>
<SENT sid="7" pm="."><plain>In order of frequency, the <z:hpo ids='HP_0001402'>hepatocellular-carcinoma</z:hpo> is the most frequent and it is usually single; followed by the <z:mpath ids='MPATH_270'>adenoma</z:mpath> which is usually multiple </plain></SENT>
<SENT sid="8" pm="."><plain>The other types of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e> are rare: focal nodular <z:mpath ids='MPATH_134'>hyperplasia</z:mpath>, <z:mp ids='MP_0003667'>angiosarcoma</z:mp> and <z:mpath ids='MPATH_354'>cholangiocarcinoma</z:mpath> </plain></SENT>
<SENT sid="9" pm="."><plain>The <z:hpo ids='HP_0001402'>hepatocellular-carcinoma</z:hpo> and <z:mpath ids='MPATH_270'>adenoma</z:mpath> have some characteristic features: spontaneous regression may occur after withdrawing of <z:chebi fb="5" ids="50113">androgens</z:chebi>; the risk of rupture is important; their evolution is almost always favorable despite of a severe histopathological picture; the alpha-foeto-protein is nearly always negative; and the <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> are exceptional </plain></SENT>
<SENT sid="10" pm="."><plain>The <z:hpo ids='HP_0001402'>hepatocellular-carcinomas</z:hpo> associated with <z:chebi fb="3" ids="50113">androgen</z:chebi> therapy are probably just <z:mpath ids='MPATH_270'>adenomas</z:mpath> with marked <z:mpath ids='MPATH_589'>dysplasia</z:mpath>, but their long term malignant potential remain unknown </plain></SENT>
<SENT sid="11" pm="."><plain>Except in case of rupture, surgical intervention should be postponed until the effect of discontinuing the hormonal therapy is assessed, because of the potential for spontaneous regression </plain></SENT>
<SENT sid="12" pm="."><plain>The administration of <z:chebi fb="0" ids="35610">antineoplastic</z:chebi> chemotherapeutic agents should be reserved for the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e> showing evidence of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e> </plain></SENT>
</text></document>